Postmenopausal Osteoporosis

IF 4.8 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Endocrinology and Metabolism Clinics of North America Pub Date : 2024-10-05 DOI:10.1016/j.ecl.2024.08.008

Prathayini Subarajan DO , Rod Marianne Arceo-Mendoza MD , Pauline M. Camacho MD

引用次数: 0

查看原文本刊更多论文

绝经后骨质疏松症：最新指南回顾。

骨质疏松症的特点是骨转换增加和骨量减少，导致骨骼脆弱和骨折风险增加。骨质疏松症是一个日益严重的公共健康问题，预计到 2030 年，骨折人数将继续大幅增加 50%。诊断通常以身体矿物质密度为依据，T 值为 -2.5 或更低表示骨质疏松症。治疗时间长短不一，取决于对骨折风险的仔细监测和潜在药物休药期的时间安排。新兴疗法和正在进行的研究不断改进骨质疏松症的治疗方法，旨在降低骨折风险，改善患者预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Endocrinology and Metabolism Clinics of North America 医学-内分泌学与代谢

CiteScore

8.00

自引率

0.00%

发文量

审稿时长

6 months

期刊介绍： Endocrinology and Metabolism Clinics of North America updates you on the latest trends in patient management, keeps you abreast of the newest advances, and provides a sound basis for choosing treatment options. Published quarterly—in March, June, September, and December—each issue features expert, state-of-the-art reviews on a single topic, including obesity, diabetes, thyroid disease, bone disorders, reproduction, hypertension, and much more.